PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release (PANTOPRAZOLE SODIUM GRANULES)
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release (PANTOPRAZOLE SODIUM GRANULES) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release; Generic name: PANTOPRAZOLE SODIUM GRANULES; Manufacturer: Cipla USA Inc..
| Brand name | PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release |
|---|---|
| Generic name | PANTOPRAZOLE SODIUM GRANULES |
| Manufacturer | Cipla USA Inc. |
| Used for | 1 INDICATIONS AND USAGE Pantoprazole sodium for delayed-release oral suspension is indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) ( 1.1 ) Maintenance of Healing of Erosive Esophagitis ( 1.2 ) Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome ( 1.3 ) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium for delayed-release oral suspension is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 |
| Dosage | 2 DOSAGE AND ADMINISTRATION Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD ( 2.1 ) Adults 40 mg Once Daily for up to 8 wks Children (5 years and older) ≥ 40 kg 40 mg Once Daily for up to 8 wks Maintenance of Healing of Erosive Esophagitis ( 2.1 ) Adults 40 mg Once Daily* Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome ( 2.1 ) Adults 40 mg Twice Daily * Controlled studies did not extend beyond 12 months See full prescribing i |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=195e06db-b76c-4470-b6a5-a3979c25046d |